ArticleInternational journal of molecular medicine2020

CDK5 inhibition in vitro and in vivo induces cell death in myeloma and overcomes the obstacle of bortezomib resistance.

Hailong Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.